Sales and Marketing

Showing 15 posts of 11524 posts found.

Government drops generic substitution plans

October 15, 2010 Sales and Marketing NHS, generics, government

The coalition government has dropped plans to implement generic substitution in England. The Pharmaceutical Price Regulation Scheme (PPRS), a scheme …

Celgene completes Abraxis takeover

October 15, 2010 Research and Development, Sales and Marketing Abraxane, Abraxis, Celgene, mergers and acquisitions, oncology

Celgene has completed its acquisition of Abraxis BioScience for cash and stock totalling $2.9 billion. The takeover gives the cancer …

NICE rejects GSK Tyverb appeal

October 14, 2010 Sales and Marketing GlaxoSmithKline, NICE, Tyverb

NICE’s independent appeal board has ruled the UK drug’s watchdog did not exceed its powers when issuing guidance on GlaxoSmithKline’s …

China driving global pharma growth

October 13, 2010 Sales and Marketing China, emerging markets, sales

The global pharma market is forecast to reach $880 billion by 2011, driven by growth in the Chinese market. Analysts …

Pfizer acquires King Pharmaceuticals for $3.6bn

October 13, 2010 Sales and Marketing King Pharmaceuticals, Pfizer, pain therapeutics

Pfizer is to purchase King Pharmaceuticals for $3.6 billion to significantly strengthen its pain portfolio and continue to diversify its …

NICE unmoved on Takeda bone cancer drug

October 13, 2010 Sales and Marketing Mepact, NICE, Takeda

NICE has refused to recommend Takeda’s Mepact because of its “exceptionally high cost” and the “substantial uncertainty” about the osteosarcoma …

Merck will appeal EMA’s Movectro decision

October 12, 2010 Sales and Marketing CHMP, EMA, Merck KGaA, Merck Serono, Movectro

Merck KGaA is poised to appeal the EMA’s decision on its MS treatment Movectro after the regulator rejected the drug …

UniversalProcon expands UK team

October 11, 2010 Sales and Marketing UniversalProcon, appointment, sales and marketing

Transatlantic event management company UniversalProcon has expanded its UK operations with five new appointments. Sophie Limbert (pictured) joins as a …

ABPI’s Barker to step down

October 11, 2010 Sales and Marketing ABPI, appointment, sales and marketing

ABPI director general Dr Richard Barker is to step down in 2011 after six years at the helm of the …

Abbott withdraws anti-obesity drug amid safety worries

October 11, 2010 Sales and Marketing Abbott, Meridia, obesity

Abbott has pulled its anti-obesity drug Meridia in the US after recent trials showed it increased the risk of stroke …

Boehringer pulls ‘Pink Viagra’

October 11, 2010 Sales and Marketing Boehringer, Girosa

Boehringer Ingelheim has discontinued development of its hypoactive sexual desire disorder drug Girosa after the FDA refused to approve it. …

Sanofi slashes US workforce

October 11, 2010 Sales and Marketing Sanofi-Aventis, job cuts

Sanofi-Aventis is to cut a quarter of its workforce in the US – making 1,700 people redundant – as it …

AZ plans heart attack study for Brilique

October 8, 2010 Research and Development, Sales and Marketing AstraZeneca, Brilinta, Brilique

AstraZeneca is due to begin enrolling patients into a new study of its oral antiplatelet Brilique (ticagrelor) before the end …

Battle for Alzheimer’s drugs finally over

October 8, 2010 Sales and Marketing Alzheimer's, Aricept, NICE

NICE is to allow wider access to Alzheimer’s disease treatments, ending an epic five year battle for access to the …
Jonathan_Claire

Trio of appointments at 4Sight

October 7, 2010 Sales and Marketing 4Sight, appointment, sales and marketing

Bracknell, UK-based Commercial services company 4Sight has made three high-level appointments. Jonathan Hartless (pictured) joins as operations director from an …
The Gateway to Local Adoption Series

Latest content